Astera Labs, Inc. Work in process increased by 30.3% to $46.57M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 65.1%, from $28.20M to $46.57M. Over 2 years (FY 2023 to FY 2025), Work in process shows an upward trend with a 74.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.78M | $12.51M | $10.92M | $10.58M | $26.70M | $28.20M | $24.10M | $16.93M | $35.75M | $46.57M |
| QoQ Change | — | +6.2% | -12.8% | -3.1% | +152.4% | +5.7% | -14.5% | -29.8% | +111.1% | +30.3% |
| YoY Change | — | — | — | — | +126.6% | +125.4% | +120.8% | +60.1% | +33.9% | +65.1% |
| % of Inventories | 48.9% | 42.3% | 38.2% | 43.3% | 61.8% | 55.2% | 41.1% | 32.8% | 60.6% | 77.4% |
| Share Change | — | -6.6pp | -4.1pp | +5.1pp | +18.5pp | -6.5pp | -14.1pp | -8.4pp | +27.8pp | +16.8pp |